ArticleMedecine tropicale et sante internationale2026
[Care pathway for children with sickle cell disease admitted to the pediatric emergency department at the Cocody University Hospital (Abidjan, Ivory Coast) from January to December 2024].
Article in Medecine tropicale et sante internationale, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Sickle cell disease leads to numerous complications that require frequent medical care. This study aimed to analyze the care pathway of children with severe sickle cell syndrome who were admitted to the pediatric emergency department at Cocody University Hospital. The goal was to identify factors associated with delayed consultation and promote the early and appropriate management of complications. Methodology: This retrospective descriptive study was conducted in the pediatrics department at Cocody University Hospital from January 1 to December 31, 2024. Children with major sickle cell syndrome and a known electrophoretic profile who were hospitalized for an acute complication of the disease were included in the study. The care pathway was analyzed. Data were entered and analyzed using Excel software. Fisher's exact test was used to compare proportions, setting the significance threshold at 5% (p < 0.05). Results: Of the 800 admissions, 60 children with major sickle cell disease were included, representing a hospital prevalence of 7.5%. The mean age was 5.38 years, ranging from six months to 14 years. The sex ratio was 1.07. Fifty percent of the patients were diagnosed before the age of two, often due to clinical manifestations such as anemia (35%), vaso-occlusive crises (18.3%), and hand-foot syndrome (16.7%). The mean age at diagnosis was 1.8 years ± 8.9, ranging from three months to 12 years. Follow-up was inadequate in 61.7% of cases. In 68.3% of cases, vaccination status was incomplete or undocumented. Patients were referred from a health center in 50% of cases. Of those who received treatment prior to referral, 73.3% were included in the study. The most commonly prescribed drug classes in the outpatient setting were analgesics/antipyretics, antimalarials, and antibiotics, accounting for 63.3%, 23.3%, and 60% of cases, respectively. Delayed consultation was observed in 71.7% of cases and was associated with unfavorable socioeconomic status (p = 0.036), self-medication (p = 0.023), use of traditional medicine (p = 0.02), poor follow-up quality (p < 10 Conclusion: This study highlights several shortcomings in the care pathway for children with sickle cell disease, particularly delays in seeking medical consultation linked to socioeconomic and cultural factors. A more structured, educational approach to care is essential to improving their prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.